Brian Walker

50PUBLICATIONS
209CO-AUTHORS
Gene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical molecular engineering of nucleic acids and proteinsPredictive and prognostic markersHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (50)

|Jul 29, 2026
SGLT-2 Inhibitors are Associated With a Lower Risk of Multiple Myeloma.

|Jul 28, 2026
Navigating the Therapeutic Landscape of Multiple Myeloma: Immunotherapy, Microenvironment, and Resistance.

|Oct 15, 2025
Diagnostic sequencing identifies high-risk markers and mechanisms of resistance to guide immunotherapy selection.

Parvathi Sudha, Phillip Pham, Wen Niu

|Jun 09, 2025
International Myeloma Society/International Myeloma Working Group Consensus Recommendations on the Definition of High-Risk Multiple Myeloma.

Hervé Avet-Loiseau, Faith E Davies, Mehmet K Samur

|May 21, 2025
Genomic landscape of multiple myeloma and its precursor conditions.

Jean-Baptiste Alberge, Ankit K Dutta, Andrea Poletti

|May 08, 2025
Identification of the Distinct Immune Microenvironment Features Associated with Progression Following High-Dose Melphalan and Autologous Stem Cell Transplant in Multiple Myeloma.

Parvathi Sudha, Travis S Johnson, Habib Hamidi

Pageof 9

Frequent Collaborators

15 joint publications

Gareth Morgan

12 joint publications

Michael Bauer

12 joint publications

Cody Ashby

9 joint publications

Ola Landgren